ArticleFrontiers in oncology2023

Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report.

Elisa Tassinari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.